For the purposes of this Regulation, the following definitions apply in addition to the definitions set out in Directive 90/385/EEC and Directive 93/42/EEC:
‘cell’ means the smallest organised unit of any living form which is capable of independent existence and of replacement of its own substance in a suitable environment;
‘tissue’ means an organisation of cells, extra-cellular constituents or both;
‘derivative’ means a material obtained from animal tissue through one or more treatments, transformations or steps of processing;
‘non-viable’ means having no potential for metabolism or multiplication;
‘TSEs’ means all transmissible spongiform encephalopathies as defined in Article 3(1)(a) of Regulation (EC) No 999/2001 of the European Parliament and of the Council [OJ L 147, 31.5.2001, p. 1.];
‘TSE infectious agents’ means unclassified pathogenic agents which are capable of transmitting TSEs;
‘reduction, elimination or removal’ means a process by which the number of TSE infectious agents is reduced, eliminated or removed in order to prevent infection or pathogenic reaction;
‘inactivation’ means a process by which the ability to cause infection or pathogenic reaction by TSE infectious agents is reduced;
‘source country’ means the country or countries in which the animal was born, has been reared and/or has been slaughtered;
‘starting materials’ means raw materials or any other product of animal origin out of which, or with the help of which, the devices referred to in Article 1(1) are produced.